Company Filing History:
Years Active: 2010-2012
Title: Alessandra Moretti: Innovator in Cardiac Progenitor Research
Introduction
Alessandra Moretti is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of cardiac progenitor research, holding 2 patents that focus on innovative methods for cardiac repair and regeneration.
Latest Patents
Her latest patents include "Methods of identifying small molecules for renewals, survival and migration of cardiac progenitors." This invention relates to a small molecule high-throughput screening assay that utilizes detectably labeled cardiac progenitor cells. The patent describes a method for identifying small molecules that affect cardiogenesis and modulate cardiac progenitor cell development. Additionally, it outlines methods for stimulating the maturation of cardiac progenitor cells using a GSK-3β inhibitor. Another notable patent is "Use of islet 1 as a marker for isolating or generating stem cells." This invention provides in vitro methods for the expansion and propagation of undifferentiated progenitor cells, specifically those containing Islet1, a marker unique to proliferating cardiac stem cells. The methods described aim to isolate stem cell populations and provoke the expansion of undifferentiated progenitor cells without differentiation, ultimately contributing to cardiac repair and improved cardiac function.
Career Highlights
Alessandra Moretti is affiliated with the University of California, where she continues her research and innovation in the field of cardiac health. Her work has garnered attention for its potential impact on regenerative medicine and cardiac therapies.
Collaborations
She collaborates with notable colleagues, including Sylvia Evans and Ju Chen, who contribute to her research endeavors and enhance the collaborative environment in her field.
Conclusion
Alessandra Moretti's innovative work in cardiac progenitor research exemplifies the potential of scientific advancements in improving heart health. Her patents reflect a commitment to developing methods that could revolutionize cardiac repair and regeneration.